Home/Filings/4/0001415889-24-018457
4//SEC Filing

Person Julie 4

Accession 0001415889-24-018457

CIK 0001923840other

Filed

Jun 27, 8:00 PM ET

Accepted

Jun 28, 4:51 PM ET

Size

14.7 KB

Accession

0001415889-24-018457

Insider Transaction Report

Form 4
Period: 2024-06-26
Person Julie
CHIEF ADMINISTRATIVE OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2024-06-26$4.20/sh+10,000$42,00010,000 total
  • Sale

    Common Stock

    2024-06-26$12.46/sh10,000$124,5690 total
  • Exercise/Conversion

    Employee Option Grant (right to buy)

    2024-06-2610,000165,962 total
    Exercise: $4.20Exp: 2032-07-27Common Stock (10,000 underlying)
Footnotes (3)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated March 27, 2024.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.90 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]25% of the total shares vest on June 20, 2023, and thereafter 6.25% of the total shares underlying the award shall vest in equal quarterly installments until fully vested, subject to the Reporting Person's continued service to the Issuer on each vesting date.

Issuer

Third Harmonic Bio, Inc.

CIK 0001923840

Entity typeother

Related Parties

1
  • filerCIK 0001946505

Filing Metadata

Form type
4
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:51 PM ET
Size
14.7 KB